Trupanion (NASDAQ:TRUP – Get Free Report) was upgraded by research analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued on Thursday, Marketbeat.com reports. The brokerage presently has a $57.00 price target on the financial services provider’s stock. Piper Sandler’s price objective points to a potential upside of 22.53% from the company’s current price.
A number of other research firms have also recently weighed in on TRUP. Stifel Nicolaus boosted their target price on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $45.33.
Read Our Latest Stock Report on TRUP
Trupanion Stock Down 1.8 %
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the previous year, the company earned ($0.10) earnings per share. The firm’s revenue for the quarter was up 14.6% compared to the same quarter last year. Research analysts predict that Trupanion will post -0.2 EPS for the current fiscal year.
Insider Activity at Trupanion
In related news, CFO Fawwad Qureshi sold 9,867 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $53.08, for a total transaction of $523,740.36. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Emily Dreyer sold 3,100 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the sale, the senior vice president now directly owns 24,708 shares in the company, valued at $1,355,233.80. This trade represents a 11.15 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 28,597 shares of company stock worth $1,522,082. 5.50% of the stock is owned by corporate insiders.
Institutional Trading of Trupanion
Hedge funds and other institutional investors have recently bought and sold shares of the company. Wellington Management Group LLP increased its holdings in shares of Trupanion by 4.4% in the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after buying an additional 142,156 shares during the last quarter. FMR LLC increased its holdings in shares of Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after buying an additional 1,170,202 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after buying an additional 116,496 shares during the last quarter. DF Dent & Co. Inc. increased its holdings in shares of Trupanion by 27.8% in the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock worth $15,443,000 after buying an additional 80,014 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Trupanion in the 2nd quarter worth $4,739,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- Are Penny Stocks a Good Fit for Your Portfolio?
- Supercharge Your Portfolio With These 3 Key Stocks
- Top Stocks Investing in 5G Technology
- Tide Shifts for 3M: How to Profit from the Rally
- Most active stocks: Dollar volume vs share volume
- Palantir Technologies: Another Stellar Year Ahead for the Stock?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.